Longboard Pharmaceuticals... (LBPH)
NASDAQ: LBPH
· Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM
Longboard Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -13.23 | -13.8 | -12.4 | -2.4 | -2.52 | -2.81 | -1.87 | -1.28 | -1.41 | -1.16 | -2.38 | -2.37 | -5.88 | -5.5 | -12.12 |
PEG Ratio | -1.06 | -0.41 | 0.37 | -0.16 | 0.16 | -0.14 | 0.12 | 0.42 | 0.95 | -0.06 | -0.31 | -0.06 | 0.80 | -0.27 | 0.28 |
PS Ratio | n/a | n/a | n/a | 18.03K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.72 | 4.08 | 2.37 | 3.53 | 2.51 | 2.90 | 1.13 | 0.91 | 0.89 | 0.64 | 0.97 | 0.80 | 1.34 | 1.31 | 2.31 |
P/FCF Ratio | -63.05 | -62.84 | -48.99 | -13.08 | -9.83 | -12.53 | -6.25 | -5.8 | -6.48 | -6.22 | -9.1 | -14.63 | -24.28 | -29.8 | -35.68 |
P/OCF Ratio | -63.05 | -62.84 | -48.99 | -13.08 | -9.83 | -12.53 | -6.25 | -5.8 | -6.48 | -6.22 | -9.1 | -14.64 | -24.34 | -29.8 | -35.68 |
OCF/S Ratio | n/a | n/a | n/a | -1.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | n/a | n/a |
Quick Ratio | 15.97 | 20.95 | 31.43 | 5.14 | 8.69 | 8.30 | 10.91 | 7.97 | 9.79 | 11.95 | 14.98 | 19.91 | 28.67 | 36.87 | 30.57 |
Current Ratio | 15.97 | 20.95 | 31.43 | 5.14 | 8.69 | 8.30 | 10.91 | 7.97 | 9.79 | 11.95 | 14.98 | 19.91 | 28.67 | 36.87 | 30.57 |
Asset Turnover | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.09 | -0.07 | -0.05 | -0.37 | -0.25 | -0.26 | -0.15 | -0.18 | -0.16 | -0.14 | -0.1 | -0.08 | -0.06 | -0.06 | -0.05 |
Return on Assets | -0.08 | -0.07 | -0.05 | -0.3 | -0.22 | -0.23 | -0.14 | -0.16 | -0.14 | -0.13 | -0.1 | -0.08 | -0.05 | -0.06 | -0.05 |
Return on Invested Capital | -0.1 | -0.09 | -0.06 | -0.38 | -0.26 | -0.27 | -0.16 | -0.18 | -0.16 | -0.14 | -0.1 | -0.08 | -0.06 | -0.06 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 0.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -1.88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -1.88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -1.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -1.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |